Inflammatory biomarkers of coronary heart disease

Hongyu Li1, Kai Sun2, Ruiping Zhao3

  • 1Department of Cardiology, Baotou Central Hospital, Baotou, China.

Insights

Coronary heart disease (CHD) involves arterial plaque buildup, leading to angina and heart attacks. Inflammatory biomarkers like C-reactive protein (CRP) help assess CHD severity and prognosis.

Area of Science:

  • Cardiovascular Medicine
  • Immunology
  • Pathophysiology

Background:

  • Coronary heart disease (CHD) is a major global cause of mortality.
  • Pathologically, CHD involves arterial plaque formation (lipids, calcium, inflammatory cells) narrowing coronary arteries.
  • Plaque rupture can cause thrombus formation, leading to myocardial infarction and death, often exacerbated by risk factors like obesity, diabetes, and hypertension.

Purpose of the Study:

  • To highlight the role of inflammation in CHD pathogenesis.
  • To underscore the diagnostic and prognostic significance of inflammatory biomarkers in CHD.

Main Methods:

  • Diagnosis of CHD relies on assessing blood lipid profiles (cholesterol, triglycerides, lipoproteins).
  • Assessment of CHD severity and prognosis involves measuring inflammatory biomarkers.
  • Key inflammatory biomarkers include interleukin-6, C-reactive protein (CRP), complement, CD40, and myeloperoxidase (MPO).

Main Results:

  • Inflammation is a significant factor in the development and progression of CHD.
  • Elevated levels of specific inflammatory biomarkers correlate with CHD severity and prognosis.

Conclusions:

  • Understanding the inflammatory component of CHD is crucial for effective management.
  • Monitoring inflammatory biomarkers offers valuable insights into patient outcomes for coronary heart disease.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
631
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
969
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
316
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.2K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.3K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
695